Monitoring asthma attacks at home using spirometry
The Use of Home Spirometry in the Monitoring of Patients With Acute Exacerbation of Asthma
NA · Chang Gung Memorial Hospital · NCT05603494
This study is testing if using a home device to check breathing can help people with asthma better manage their symptoms during flare-ups.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 20 Years to 75 Years |
| Sex | All |
| Sponsor | Chang Gung Memorial Hospital (other) |
| Drugs / interventions | prednisone |
| Locations | 1 site (Taoyuan) |
| Trial ID | NCT05603494 on ClinicalTrials.gov |
What this trial studies
This study involves asthmatic patients experiencing acute exacerbations who will use home spirometry to monitor their symptoms over a 14-day period. After an outpatient clinic visit, participants will record their symptoms and spirometry data daily, allowing for real-time assessment of their condition. The study aims to evaluate the effectiveness of home monitoring in managing asthma exacerbations and improving patient outcomes.
Who should consider this trial
Good fit: Ideal candidates are asthmatic individuals aged 20 to 75 who are currently under regular treatment and experiencing acute exacerbation symptoms.
Not a fit: Patients with chronic obstructive pulmonary disease or those unable to use a smartphone may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance asthma management and reduce the frequency and severity of exacerbations for patients.
How similar studies have performed: Other studies have shown promise in using home monitoring for asthma management, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 20 to 75 years old asthmatic patients under regular treatment for at least 3 months. * Patients in asthma acute exacerbation (symptoms onset within 1 week) and received oral corticosteroid for more than 3 days. Exclusion Criteria: * Refuse to provide inform consent. * Patients with chronic obstructive pulmonary disease. * Patients who receive more than 20mg prednisone or equivalent dose per day. * Patients who are incapable of using smart phone.
Where this trial is running
Taoyuan
- Chiung-Hung — Taoyuan, Taiwan (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Asthma Attack